[Anticoagulant treatment in women during pregnancy, at childbirth and during puerperium--safety and effectiveness].

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Author(s): Undas A
  • Source:
    Przeglad lekarski [Przegl Lek] 2015; Vol. 72 (4), pp. 217-22.
  • Publication Type:
    English Abstract; Journal Article; Review
  • Language:
    Polish
  • Additional Information
    • Transliterated Title:
      Leczenie przeciwkrzepliwe u kobiet w ciązy, w czasie porodu i połogu--bezpieczeństwo i skuteczność.
    • Source:
      Publisher: Wydawnicto Przeglad Lekarski Country of Publication: Poland NLM ID: 19840720R Publication Model: Print Cited Medium: Print ISSN: 0033-2240 (Print) Linking ISSN: 00332240 NLM ISO Abbreviation: Przegl Lek Subsets: MEDLINE
    • Publication Information:
      Original Publication: Kraków : Wydawnicto Przeglad Lekarski
    • Subject Terms:
      Anticoagulants/*therapeutic use ; Pregnancy Complications, Cardiovascular/*drug therapy ; Puerperal Disorders/*drug therapy ; Venous Thromboembolism/*drug therapy; Anticoagulants/adverse effects ; Drug Monitoring/methods ; Female ; Fetal Diseases/chemically induced ; Hemorrhage/chemically induced ; Humans ; Parturition ; Pregnancy ; Pregnancy Complications, Cardiovascular/chemically induced
    • Abstract:
      Pregnancy and puerperium, defined as the first 6 weeks after childbirth, represent physiological prothrombotic states that result in increased risk of venous thromboembolism with the highest prevalence during puerperium and valve thrombosis in women with implanted cardiac prosthesis. The use of vitamin K antagonists, heparins, or any combination of these agents, especially in women following heart valve implantation, has potentially adverse outcomes for the mother and fetus, largely related to thrombotic or hemorrhagic complications. There is agreement that failures in anticoagulation on obstetrical patients are most often due to underdosing and the lack of appropriate laboratory monitoring. This review summarizes the current data on anticoagulant therapy in pregnant women with the emphasis placed on practical implications and clinical practice guidelines.
    • Accession Number:
      0 (Anticoagulants)
    • Publication Date:
      Date Created: 20151013 Date Completed: 20151130 Latest Revision: 20151012
    • Publication Date:
      20231215
    • Accession Number:
      26455024